Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

XenoPort Inc - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 24/12/2007
  • Report Title: XenoPort Inc - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 47
Introduction

XenoPort is a biopharmaceutical company with therapeutic focus in the areas of central nervous system (CNS) and gastrointestinal tract (GI). Its product pipeline is based on its proprietary Transported Prodrug technology platform, which is focused on improving upon the pharmacologic properties of currently available therapeutics.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    XenoPort's pipeline includes XP19986, indicated for gastro-esophageal reflux disease (Phase IIa) and spasticity (Phase I), and XP13512 indicated for Restless Legs Syndrome (Phase III) and neuropathic pain (Phase IIa).

    The key elements ofit's business strategy include: entering into strategic alliances with other pharmaceutical/biotechnology companies for discovery, development and commercialization of its product candidates; advancing clinical development of its product candidates; and Transported Prodrug to discover new product candidates.

    The company's total revenues increased at a CAGR of 99.2% during 2002-2006, from $0.7 million to $10.6 million. The company's only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic